| Barbara Lock, MD | |
|
16 Guion Pl, Sound Shore Medical Center Of Westchester (emerg Dept), New Rochelle, NY 10801-5503 | |
| (914) 632-5000 | |
| Not Available |
| Full Name | Barbara Lock |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 27 Years |
| Location | 16 Guion Pl, New Rochelle, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629015359 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 211863-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York-presbyterian Hospital | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trustees Of Columbia University In The City Of New York | 8527972546 | 1895 |
News Archive
Young adults who frequently binge drink were more likely to have certain risk factors for cardiovascular disease than non-binge drinkers, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has closed on its $20 million Series C financing. The financing was led by CHL Medical Partners and also included significant participation by many of the Company's existing investors; Abingworth, InterWest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Company and the Invus Group.
UK researchers think they are close to finding the first effective treatment to fight one of the biggest killer diseases in the UK. Professor Peter Barnes will present the work at the British Endocrine Societies 2005 meeting in Harrogate.
Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center have reached an early, but important, milestone in the quest to grow replacement livers in the lab. They are the first to use human liver cells to successfully engineer miniature livers that function - at least in a laboratory setting like human livers. The next step is to see if the livers will continue to function after transplantation in an animal model.
Developmental biologists at the University of Pittsburgh have been chosen to participate in a $100 million federal "Bench to Bassinet" network that is dedicated to learning about the formation of the cardiovascular system and applying that knowledge to create new diagnostic and intervention strategies for congenital heart disease.
› Verified 8 days ago
| Entity Name | Trustees Of Columbia University In The City Of New York |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982993184 PECOS PAC ID: 8527972546 Enrollment ID: O20040407001360 |
News Archive
Young adults who frequently binge drink were more likely to have certain risk factors for cardiovascular disease than non-binge drinkers, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has closed on its $20 million Series C financing. The financing was led by CHL Medical Partners and also included significant participation by many of the Company's existing investors; Abingworth, InterWest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Company and the Invus Group.
UK researchers think they are close to finding the first effective treatment to fight one of the biggest killer diseases in the UK. Professor Peter Barnes will present the work at the British Endocrine Societies 2005 meeting in Harrogate.
Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center have reached an early, but important, milestone in the quest to grow replacement livers in the lab. They are the first to use human liver cells to successfully engineer miniature livers that function - at least in a laboratory setting like human livers. The next step is to see if the livers will continue to function after transplantation in an animal model.
Developmental biologists at the University of Pittsburgh have been chosen to participate in a $100 million federal "Bench to Bassinet" network that is dedicated to learning about the formation of the cardiovascular system and applying that knowledge to create new diagnostic and intervention strategies for congenital heart disease.
› Verified 8 days ago
| Entity Name | Trustees Of Columbia University In The City Of New York |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073524369 PECOS PAC ID: 9133114341 Enrollment ID: O20040417000035 |
News Archive
Young adults who frequently binge drink were more likely to have certain risk factors for cardiovascular disease than non-binge drinkers, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has closed on its $20 million Series C financing. The financing was led by CHL Medical Partners and also included significant participation by many of the Company's existing investors; Abingworth, InterWest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Company and the Invus Group.
UK researchers think they are close to finding the first effective treatment to fight one of the biggest killer diseases in the UK. Professor Peter Barnes will present the work at the British Endocrine Societies 2005 meeting in Harrogate.
Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center have reached an early, but important, milestone in the quest to grow replacement livers in the lab. They are the first to use human liver cells to successfully engineer miniature livers that function - at least in a laboratory setting like human livers. The next step is to see if the livers will continue to function after transplantation in an animal model.
Developmental biologists at the University of Pittsburgh have been chosen to participate in a $100 million federal "Bench to Bassinet" network that is dedicated to learning about the formation of the cardiovascular system and applying that knowledge to create new diagnostic and intervention strategies for congenital heart disease.
› Verified 8 days ago
| Entity Name | Trustees Of Columbia University In The City Of New York |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508266347 PECOS PAC ID: 8527972546 Enrollment ID: O20151201002613 |
News Archive
Young adults who frequently binge drink were more likely to have certain risk factors for cardiovascular disease than non-binge drinkers, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has closed on its $20 million Series C financing. The financing was led by CHL Medical Partners and also included significant participation by many of the Company's existing investors; Abingworth, InterWest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Company and the Invus Group.
UK researchers think they are close to finding the first effective treatment to fight one of the biggest killer diseases in the UK. Professor Peter Barnes will present the work at the British Endocrine Societies 2005 meeting in Harrogate.
Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center have reached an early, but important, milestone in the quest to grow replacement livers in the lab. They are the first to use human liver cells to successfully engineer miniature livers that function - at least in a laboratory setting like human livers. The next step is to see if the livers will continue to function after transplantation in an animal model.
Developmental biologists at the University of Pittsburgh have been chosen to participate in a $100 million federal "Bench to Bassinet" network that is dedicated to learning about the formation of the cardiovascular system and applying that knowledge to create new diagnostic and intervention strategies for congenital heart disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Lock, MD Po Box 658, Livingston, NJ 07039-0658 Ph: (973) 740-0607 | Barbara Lock, MD 16 Guion Pl, Sound Shore Medical Center Of Westchester (emerg Dept), New Rochelle, NY 10801-5503 Ph: (914) 632-5000 |
News Archive
Young adults who frequently binge drink were more likely to have certain risk factors for cardiovascular disease than non-binge drinkers, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has closed on its $20 million Series C financing. The financing was led by CHL Medical Partners and also included significant participation by many of the Company's existing investors; Abingworth, InterWest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Company and the Invus Group.
UK researchers think they are close to finding the first effective treatment to fight one of the biggest killer diseases in the UK. Professor Peter Barnes will present the work at the British Endocrine Societies 2005 meeting in Harrogate.
Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center have reached an early, but important, milestone in the quest to grow replacement livers in the lab. They are the first to use human liver cells to successfully engineer miniature livers that function - at least in a laboratory setting like human livers. The next step is to see if the livers will continue to function after transplantation in an animal model.
Developmental biologists at the University of Pittsburgh have been chosen to participate in a $100 million federal "Bench to Bassinet" network that is dedicated to learning about the formation of the cardiovascular system and applying that knowledge to create new diagnostic and intervention strategies for congenital heart disease.
› Verified 8 days ago
Hyun Chung, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 16 Guion Pl, Sound Shore Medical Center Of Westchester, New Rochelle, NY 10801 Phone: 914-632-5000 | |
Michael Lahn, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 16 Guion Pl, Sound Shore Medical Center, New Rochelle, NY 10801 Phone: 914-632-5000 | |
Lawrence Klecatsky, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 16 Guion Pl, Sound Shore Medical Center Of Westchester, New Rochelle, NY 10801 Phone: 914-632-5000 | |
Joseph Ponticiello, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 16 Guion Place, Sound Shore Medical Center Of Westchester, New Rochelle, NY 10802 Phone: 914-632-5000 | |
Harry Livenstein, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 701 Pelham Rd, Suite 3h, New Rochelle, NY 10805 Phone: 914-654-9844 | |
Cheryl R Malina, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 77 Quaker Ridge Rd Ste 212, New Rochelle, NY 10804 Phone: 646-345-1998 | |
Ligija Rociunas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 16 Guion Pl, Sound Shore Medical Center Of Westchester, New Rochelle, NY 10801 Phone: 914-632-5000 |